Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 919-927

  Hatta, Eiichiro ^a   Maruyama, Ryushi ^a   Marshall, Stuart J ^a   Imamura, Michiaki ^a   Levi, Roberto ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ;

ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME DEGRADATION; EXOCYTOSIS; FACILITATION; GUINEA PIG; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; REPERFUSION INJURY; SYMPATHETIC NERVE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARRHYTHMIA; BRADYKININ; FEMALE; GUINEA PIGS; HEART; HUMANS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; NOREPINEPHRINE;

EID: 0033014509     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Arakawa K (1996) Serine proteinase angiotensin II systems. J Hypertens 14 (Suppl 5):S3-S7.
2. Bhoola KD, Figueroa CD and Worthy K (1992) Bioregulation of kinins: Kallikreins, kininogens, and kininases, Pharmacol Rev 44:1-80.
3. Biais C Jr, Drapeau G, Raymond P, Lamontagne D, Gervais N, Venneman I and Adam A (1997) Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: An interspecies study. Am J Physiol 273:H2263-H2271.
4. Brown NJ and Vaughan DE (1998) Angiotensin-converting enzyme inhibitors. Circulation 97:1411-1420.
5. Busse R and Fleming I (1996) Endothelial dysfunctions in atherosclerosis. J Vasc Res 33:181-194.
6. Busse R, Hecker M and Fleming I (1994) Control of nitric oxide and prostacyclin synthesis in endothelial cells. Arzneim Forsch 44:392-396.
7. Chahine R, Adam A, Yamaguchi N, Gaspo R, Regoli D and Nadeau R (1993) Protective effects of bradykinin on the ischaemic heart: Implication of the B1 receptor. Br J Pharmacol 108:318-322.
8. Chulak C, Couture R and Foucart S (1995) Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria. Br J Pharmacol 115:330-334.
9. 2 knockout transgenic mice. Eur J Pharmacol 346:167-174.
10. de Lorgeril M, Ovize M, Delaye J and Renaud S (1992) Importance of the flow perfusion deficit in the response to captopril in experimental myocardial infarction. J Cardiovasc Pharmacol 19:324-329.
11. 2 receptors. Pfluegers Arch 432 (Suppl):R99-R106.
12. Du XJ, Anderson KE, Jacobsen A, Woodcock EA and Dart AM (1995) Suppression of ventricular arrhythmias during ischemia-reperfusion by agents inhibiting Ins(1,4,5)P3 release. Circulation 91:2712-2716.
13. Fleming I, Hecker M and Busse R (1994) Intrazellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells. Circ Res 74:1220-1226.
14. Frelin C, Vigne P, Ladoux A and Lazdunski M (1988) The regulation of the intracellular pH in cells from vertebrates. Eur J Biochem 174:3-14.
15. Geppetti P (1993) Sensory neuropeptide release by bradykinin: Mechanisms and pathophysiological implications. Regul Pept 47:1-23.
16. Giannella E, Mochmann HC and Levi R (1997) Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/ reperfusion: Role of adenosine A1/A3 and bradykinin B2 receptor activation. Circ Res 81:415-422.
17. Gross DM, Sweet CS, Ulm EH, Backlund EP, Morris AA, Weitz D, Bohn DL, Wenger HC, Vassil TC and Stone CA (1981) Effect of N-[(S)-1-carboxy-3-phenvlpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin 1 pressor responses in vivo. J Pharmacol Exp Ther 216:552-557.
18. 3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia. J Pharmacol Exp Ther 283:494-500.
19. Hatta E, Yasuda K and Levi R (1997b) Serine proteinase enhances norepinephrine release and arrhythmias in myocardial ischemia/reperfusion: Role of bradykinin and angiotensin (Abstract). Circulation 96 (Suppl 1):I-498.
20. Hatta E, Rubin LE, Seyedi N and Levi R (1997c) Bradykinin and cardioprotection: Don't set your heart on it. Pharmacol Res 36:531-536.
21. Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, Konig W, Knolle J and Schölkens BA (1991) Hoe 140, a new potent and long acting bradykinin-antagonist: In vitro studies. Br J Pharmacol 102:769-773.
22. 2-adrenoceptors. Circ Res 78:475-481.
23. 3 receptors in myocardial ischemia: Their role as regulators of exocytotic norepinephrine release. J Pharmacol Exp Ther 271:1259-1266.
24. Kimura E, Hashimoto K, Furukawa S and Hayakawa H (1973) Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am Heart J 85:635-647.
25. Kubo SH, Rector TS, Bank AJ, Williams RE and Heifetz SM (1991) Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84:1589-1596.
26. 9-bradykinin release after reperfusion of the ischaemic rat heart. BrJ Pharmacol 115:476-478.
27. Linz W, Schölkens BA, Kaiser J, Just M, Qi BY, Albus U and Petry P (1989) Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril. Cardiovasc Drugs Ther 3:873-882.
28. Liu YH, Yang XP, Sharov VG, Sigmon DH, Sabbath HN and Carretero OA (1996) Paracrine systems in the cardioprotective effect of angiotenein-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 27:7-13.
29. Llona I, Galleguillos X, Belmar J and Huidobro-Toro JP (1991) Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals. Life Sci 48:2585-2592.
30. Matsuki T, Shoji T, Yoshida S, Kudoh Y, Motoe M, Inoue M, Nakata T, Hosoda S, Shimamoto K, Yellon D and Iimura O (1987) Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin. Cardiovasc Res 21:428-432.
31. 3H]noradrenaline from the human neuroblastoma SH-SY5Y. Biochem Pharmacol 48:23-30.
32. Megarry SG, Sapsford R, Hall AS and Ball SG (1997) Do ACE inhibitors provide protection for the heart in the clinical setting of acute myocardial infarction? Drugs 54 (Suppl 5):48-58.
33. 2 receptors in adult myocardium and neonatal rat cardiomyocytes. Circ Res 76:773-780.
34. Minshall RD, Vogel SM and Rabito SF (1997) Are the inotropic and antiarrhythmic effects of bradykinin due to increases in coronary flow? Am J Cardiol 80:148A-152A.
35. Minshall RD, Yelamanchi VP, Djokovic A, Miletich DJ, Erdös EG, Rabito SF and Vogel SM (1994) Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. Circ Res 74:441-447.
36. Mombouli JV, Illiano S, Nagao T, Scott-Burden T and Vanhoutte PM (1992) Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res 71:137-144.
37. O'Donnell ME and Owen NE (1994) Regulation of ion pumps and carriers in vascular smooth muscle. Physiol Rev 74:683-722.
38. Owen PJ, Plevin R and Boarder MR (1989) Characterization of bradykinin-stimulated release of noradrenaline from cultured bovine adrenal chromaffin cells. J Pharmacol Exp Ther 248:1231-1236.
39. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Suavely DB and Chang PI (1997) Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349:747-752.
40. Plununer TH Jr and Ryan TJ (1981) A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N. Biochem Biophys Res Commun 98:448-454.
41. 3Hl noradrenaline from SH-SY5Y cells. J Neurochem 64:1175-1182.
42. Regoli D and Barabé J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1-46.
43. Ribuot C, Yamaguchi N, Godin D, Jette L, Adam A and Nadeau R (1994) Intracoronary infusion of bradykinin: Effects on noradrenaline overflow after reperfusion of ischemic myocardium in the anesthetized dog. Fundam Clin Pharmacol 8:532-538.
44. Rubin LE and Levi R (1995) Protective role of bradykinin in cardiac anaphylaxis. Coronary-vasodilating and antiarrhythmic activities mediated by autocrine/ paracrine mechanisms. Circ Res 76:434-440.
45. Rump LC, Berlit T, Schwertfeger E, Beyersdorf F, Schollmeyer P and Bohmann C (1997) Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium. J Hypertens 16:1263-1270.
46. Rump LC, Bohmann C, Schaible U, Schultze-Seemann W and Schollmeyer PJ (1995) β-Adrenergic, angiotensin II, and bradykinin receptors enhance neurotransmission in human kidney. Hypertension 26:445-451.
47. Schömig A (1990) Catecholamines in myocardial ischemia: Systemic and cardiac release. Circulation 82 (Suppl 2):H-13-H-22.
48. Schwieler JH and Hjemdahl P (1992) Influence of angiotensin-converting enzyme inhibition on sympathetic neurotransmission: Possible roles of bradykinin and prostaglandins. J Cardiovasc Pharmacol 20 (Suppl 9):S39-S46.
49. Scicli AG (1994) Increases in cardiac kinins as a new mechanism to protect the heart. Hypertension 23:419-421.
50. 2 receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings: Mediation by autocrine/paracrine mechanisms. Circ Res 81:774-784.
51. Sher E, Biancardi E, Passafaro M and Clementi F (1991) Physiopathology of neuronal voltage-operated calcium channels. FASEB J 5:2677-2683.
52. Tio RA, Tobe TJ, Bel KJ, de Langen CD, van Gilst WH and Wesseling H (1991) Beneficial effects of bradykinin on porcine ischemic myocardium. Basic Res Cardiol 86:107-116.
53. van Gilst WH, de Graeff PA, Wesseling H and de Langen CDJ (1986) Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: A comparison of captopril, enalapril, and HOE 498. J Cardiovasc Pharmacol 8:722-728.
54. 2 receptors elicit a sympathoexcitatory reflex in rats. Hypertension 28:615-621.
55. 2 receptors. Br J Pharmacol 113:1167-1172.
56. + exchange system in various cell types. Biochem Biophys Res Commun 116:86-90.
57. Vita JA, Treasure CB, Yeung AC. Vekshtein VI, Fantasia GM, Fish RD, Ganz P and Selwyn AP (1992) Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 85:1390-1397.
58. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E and Woodward B (1988) The Lambeth Conventions. Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 22:447-455
59. Wang W and Zucker IH (1996) Cardiac sympathetic afferent reflex in dogs with congestive heart failure. Am J Physiol Regul Integr Comp Physiol 271:R751-R756.